Publications by authors named "Piergiorgio Scotton"

The management of the patient with fever in the intensive cardiac care unit begins with a thorough evaluation of the patient, particularly symptoms, clinical history and physical examination, to provide information regarding the origin of the fever. The global evaluation of the patient should be integrated with blood and microbiological tests, in particular blood culture and swab. The laboratory, microbiologic or radiologic tests could be more or less detailed and targeted depending on the type of suspected infection and clinical conditions of the patient.

View Article and Find Full Text PDF

This study aimed to compare the clinical progression of COVID-19 in high-risk outpatients treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and casirivimab-imdevimab. This is an observational, multi-centre, prospective study conducted from 18 March to 15 July 2021 in eight Italian tertiary-care hospitals including mild-to-moderate COVID-19 outpatients receiving bamlanivimab (700 mg), bamlanivimab-etesevimab (700-1400 mg) or casirivimab-imdevimab (1200-1200 mg). All patients were at high risk of COVID-19 progression according to Italian Medicines Agency definitions.

View Article and Find Full Text PDF

The present paper reports, to the best of our knowledge for the first time, the efficacy and tolerability of the combination of interferon (IFN)α-2a in pegylated formulation and rituximab after a "priming" phase with IFN in the frontline treatment of hairy cell leukemia (HCL) in a profoundly immunosuppressed patient with a infection at onset. This immunotherapy combination may represent a potential therapeutic option in patients with active severe infection and for whom the use of purine nucleoside analogues (PNA) is contraindicated. The benefits and drawbacks of remarkably rapid immune reconstitution in the context of opportunistic infections are highlighted as well, as the potentially paradoxical effects of immune recovery as a result of effective immunotherapy strategies, known as immune reconstitution inflammatory syndrome (IRIS), have to be taken into account when dealing with patients with opportunistic infections.

View Article and Find Full Text PDF

B cell-targeting strategies such as rituximab are widely used in B cell hematologic malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune disorders. The purpose of this paper is to illustrate how exposure to anti-CD20 treatment profoundly affects B cell functions involved in anti-SARS-CoV-2 immunity and significantly impacts on the clinical and serological course of SARS-CoV-2 infection, long term immunity and vaccine responses. The data presented here suggest that the effects of B cell-depleting agents on adaptive immunity should be taken into account for the proper selection and interpretation of SARS-CoV-2 diagnostics and to guide appropriate therapeutic approaches and protective measures.

View Article and Find Full Text PDF

• Four B cell–depleted non-Hodgkin lymphoma (NHL) patients with SARS-CoV-2 pneumonia after rituximab therapy were initially treated with a 5-day remdesivir course and steroids. After transient virologic and clinical response, they all experienced early relapse and subsequent prolonged disease course, with rapid and significant response to convalescent hyperimmune plasma in association with an extended course of remdesivir. The clinical observations here reported suggest that the immunological effects of Rituximab treatment in NHL patients should be taken into account for the proper choice and interpretation of SARS-CoV-2 laboratory tests and to guide the appropriate therapeutical approach.

View Article and Find Full Text PDF

Purpose: To describe a strategy to reduce Covid-19 spread among healthcare workers and provide ophthalmologists with recommendations useful for a possible second wave of Covid-19 in Autumn.

Methods: Epidemiological surveillance at the Cà Foncello Hospital (Veneto, Italy) since 24 February 2020 to 24 April 2020 when the municipality of Treviso was hit by the Covid-19 outbreak. The number of naso-pharigeal (NP) swabs performed was 7010.

View Article and Find Full Text PDF
Article Synopsis
  • Infective endocarditis continues to be a severe condition with high rates of illness and death, despite advancements in medical diagnostics and treatments.
  • The disease's poor outcomes may be linked to evolving patient demographics, new aggressive pathogens, and inadequate use of diagnostic tools and therapies.
  • A proposed solution is a formal multidisciplinary approach involving specialists from various fields to enhance the management and adherence to guidelines, potentially improving patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • * The introduction of a formal policy in 2003 allowed for quicker evaluations and timely surgeries within 48 hours for high-risk patients, leading to better outcomes compared to the period when no such policy was in place (1996-2002).
  • * The study indicated that even with older patients and those with more co-morbidities in the later period, the health care team's coordinated efforts decreased hospital mortality from 28% to 13% and improved survival rates over three years from 34% to 16%.
View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness of a multidisciplinary approach introduced in 2003 for treating prosthetic valve endocarditis (PVE), involving a team of specialists who rapidly assessed and treated patients.
  • - Comparison between two time periods showed that post-2003, patients were diagnosed earlier, had fewer severe complications, and experienced a significant decrease in both in-hospital and 3-year mortality rates.
  • - The collaborative treatment model resulted in more patients being successfully treated with medication alone, highlighting the benefit of structured care for those with PVE.
View Article and Find Full Text PDF

We report four imported cases of progressive disseminated histoplasmosis (PDH) due to Histoplasma capsulatum variety capsulatum in Human Immunodeficiency Virus-infected patients from West Africa. This report highlights the need to consider diagnosis of PDH among patients with acquired immunodeficiency syndrome who originate from West Africa and present with a prolonged febrile illness and very low CD4 count.

View Article and Find Full Text PDF

Background And Aim Of The Study: Numerous studies have been conducted to investigate the conditions associated with poor outcome among patients with infective endocarditis (IE). Yet, diabetes mellitus alone has rarely been analyzed as participating in the prognosis, and few data are available relating to the clinical characteristics of IE in diabetics. The study aim was to assess the influence of diabetes mellitus on the characteristics and prognosis of IE, and to identify predictors of poor outcome among diabetic patients with this condition.

View Article and Find Full Text PDF